Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal

Brain Research

Volumn 964, Issue 2, 2003, Pages 187-199

  Zhou, Yan ^a   Spangler, Rudolph ^a   Schlussman, Stefan D ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

ACTH; Anterior pituitary; Chronic 'binge' cocaine; Cocaine withdrawal; Corticosterone; CRH R1; Hypothalamic pituitary adrenal axis; POMC

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; PROOPIOMELANOCORTIN; SODIUM CHLORIDE;

ADAPTATION; ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE EATING DISORDER; COCAINE DEPENDENCE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG TOLERANCE; DRUG WITHDRAWAL; GENE EXPRESSION; HORMONAL REGULATION; HORMONE DETERMINATION; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RAT; TIME;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; AMYGDALA; ANIMALS; BLOTTING, NORTHERN; COCAINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE UPTAKE INHIBITORS; ENKEPHALINS; FRONTAL LOBE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RATS; RATS, INBRED F344; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0037469930     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03929-X     Document Type: Article

References (55)

1. Ambrosio E., Sharpe L.G., Pilotte N.S. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse. 25:1997;272-276.
2. Autelitano D.J., Clements J.A., Nikolaidis I., Canny B.J., Funder J.W. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels. Endocrinology. 121:1987;1689-1696.
3. Baumann M.H., Gendron T.M., Becketts K.M., Henningfeld J.E., Gorelick D.A., Rothman R.B. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol. Psychiatry. 38:1995;751-755.
4. Borowsky B., Kuhn C.M. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543:1991;301-306.
5. Branch A.D., Unterwald E.M., Lee S.E., Kreek M.J. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol. Brain Res. 14:1992;231-238.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Douglass J., McKinzie A.A., Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15:1995;2471-2481.
8. Forman L.J., Estilow W. Cocaine influences beta-endorphin levels and release. Life Sci. 43:1988;309-315.
9. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
10. Harbuz M.S., Rees R.G., Eckland D., Jessop D.S., Brewerton D., Lightman S.L. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology. 130:1992;1394-1400.
11. Hauger R.L., Aguilera G. Regulation of pituitary corticotropin-releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology. 133:1993;1708-1714.
12. Hollt V., Przewlocki R., Haarmann I., Almeida O.F.X., Kley N., Millan M.J., Herz A. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. Neuroendocrinology. 43:1986;277-282.
13. Jacobsen L.K., Giedd J.N., Kreek M.J., Gottschalk C., Kosten T.R. Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report. Drug Alcohol Depend. 62:2001;49-56.
14. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51:1998;23-47.
15. Levy A.Q., Li Q., Sanz M.C.A., Rittenhouse P.A., Kerr J.E., Van De Kar L.D. Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci. 51:1992;887-897.
16. Levy A.Q., Rittenhouse P.A., Li Q., Yracheta J., Kunimoto K., Van De Kar L.D. Influence of repeated cocaine exposure on the endocrine and behavioral responses to stress in rats. Psychopharmacology. 113:1994;547-554.
17. L'Hereault S., Barden N. Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus. Mol. Brain Res. 9:1991;327-332.
18. L'Hereault S., Barden N. Regulation of proopiomelanocortin messenger RNA concentrations by opioid peptides in primary cell cultures of rat hypothalamus. Mol. Brain Res. 10:1991;115-121.
19. Locatelli V., Petraglia F., Penalva A., Panarai A.E. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat. Life Sci. 33:1983;1711-1717.
20. Maisonneuve I.M., Ho A., Kreek M.J. Chronic administration of a cocaine 'binge' alters basal extracellular levels in male rats: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 272:1995;652-657.
21. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
22. Mantsch J.R., Schlussman S.D., Ho A., Kreek M.J. Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. J. Pharmacol. Exp. Ther. 294:2000;239-247.
23. Markowitz C.E., Berkowitz K.M., Jaff S.B., Wardlaw S.L. Effect of opioid receptor antagonism on proopiomelanocortin peptide levels and gene expression in the hypothalamus. Mol. Cell. Neurosci. 3:1992;184-190.
24. Mendelson J.H., Teoh S.K., Mello N.K., Ellingboe J., Rhoades E. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J. Pharmacol. Exp. Ther. 263:1992;505-509.
25. Mendelson J.H., Sholar M., Mello N., Teoh S.K., Sholar J. Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology. 18:1998;263-271.
26. Moldow R.L., Fishman A.J. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides. 8:1987;819-822.
27. Nikodemova M., Diehl C.R., Aguilera G. Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary. Arch. Physiol. Biochem. 110:2002;123-128.
28. Nikolarakis K.E., Almeida O.F.X., Herz A. Feedback inhibition of opioid peptide release in the hypothalamus of the rat. Neuroscience. 23:1987;143-148.
29. Peltier R.L., Guerin G.F., Dorairaj N., Goeders N.E. Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine. J. Pharmacol. Exp. Ther. 299:2001;114-120.
30. Pozzoli G., Bilezikjian L.M., Perrin M.H., Blount A.L., Vale W.W. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type I CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology. 137:1996;65-71.
31. Richter R., Pich E., Koob G., Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci. Lett. 187:1995;169-172.
32. Richter R., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administration rats. Synapse. 32:1999;254-261.
33. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
34. Rivier C., Lee S. Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus. Mol. Cell. Neurosci. 5:1994;189-195.
35. Sakai K., Horiba N., Sakai Y., Tozawa F., Demura H., Suda T. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology. 137:1996;1758-1763.
36. Sarnyai Z., Dhabhar F.S., McEwen B.S., Kreek M.J. Neuroendocrine-related effects of long-term 'binge' cocaine administration: diminished individual differences in stress-induced corticosterone response. Neuroendocrinology. 68:1998;334-344.
37. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53:2001;209-243.
38. Schluger J.H., Borg L., Ho A., Kreek M.J. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology. 24:2001;568-575.
39. Schmidt E.D., Tilders F.J., Janszen A.W., Binnekade R., De Vries T.J., Schoffelmeer A.N. Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats. Eur. J. Pharmacol. 285:1995;317-321.
40. Shiomi H., Watson S.J., Kelsey J.E., Akil H. Pretranslational and posttranslational mechanisms for regulation beta-endorphin-adrenocorticotropin of the anterior pituitary lobe. Endocrinology. 119:1986;1793-1799.
41. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., Kreek M.J. Dopamine antagonists and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. NeuroReport. 7:1996;2196-2200.
42. Sweep C.G.J., Wiegant V.M., De Vry J., Van Ree J.M. Beta-endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs. Life Sci. 44:1989;1133-1140.
43. Teoh S.K., Mendelson J.H., Woods B.T., Mello N.K., Hallgring E., Anfinsen P., Douglas A., Mercer G. Pituitary volume in men with concurrent heroin and cocaine dependence. J. Clin. Endocrinol. Metab. 76:1993;1529-1532.
44. Teoh S.K., Sarnyai Z., Mendelson J.H., Mello N.K., Springer S.A., Sholar J.W., Wapler M., Kuehnle J.C., Gelles H. Cocaine effects on pulsatile secretion of ACTH in men. J. Pharmacol. Exp. Ther. 270:1994;1134-1138.
45. Torres G., Rivier C. Cocaine-induced stimulation of the rat hypothalamic-pituitary-adrenal axis is progressively attenuated following hourly-interval regimens of the drug. Life Sci. 51:1992;1041-1048.
46. Unterwald E.M., Kreek M.J., Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res. 900:2001;103-109.
47. Vescovi P.P., Coiro V., Volpi R., Passeri M. Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts. Horm. Res. 37:1992;221-224.
48. Wardlaw S.L., Kim J., Sobieszczyk S. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Mol. Brain Res. 41:1996;140-147.
49. Yuferov V., Mantsch J.R., Ho A., Mathieu-Kia A.M., Kreek M.J. Hypothalamic-pituitary-adrenal axis alterations in a rat self-administration model of cocaine addiction. Drug Alcohol Depend. 63:2001;S175.
50. Zhou Y., Spangler R., LaForge K.S., Maggos C., Ho A., Kreek M.J. Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during 'binge' pattern cocaine administration and chronic withdrawal. J. Pharmacol. Exp. Ther. 279:1996;351-358.
51. Zhou Y., Spangler R., LaForge K.S., Maggos C., Ho A., Kreek M.J. Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA. Peptides. 17:1996;435-441.
52. Zhou Y., Schlussman S.D., Ho A., Spangler R., Fienberg A.A., Greengard P., Kreek M.J. Effects of chronic 'binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. Neuroendocrinology. 70:1999;196-199.
53. 1 receptor mRNAs after acute, but not chronic, daily 'binge' intragastric alcohol administration. Alcohol. Clin. Exp. Res. 24:2000;1575-1582.
54. 1 dopamine receptor blockade. Mol. Brain Res. 94:2001;112-118.
55. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology. 158:2001;374-381.